109 related articles for article (PubMed ID: 38818624)
1. A theoretical study on the activity and selectivity of IDO/TDO inhibitors.
Wujieti B; Feng X; Liu E; Li D; Hao M; Zhou L; Cui W
Phys Chem Chem Phys; 2024 Jun; 26(23):16747-16764. PubMed ID: 38818624
[TBL] [Abstract][Full Text] [Related]
2. Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase.
Capece L; Arrar M; Roitberg AE; Yeh SR; Marti MA; Estrin DA
Proteins; 2010 Nov; 78(14):2961-72. PubMed ID: 20715188
[TBL] [Abstract][Full Text] [Related]
3. The first step of the dioxygenation reaction carried out by tryptophan dioxygenase and indoleamine 2,3-dioxygenase as revealed by quantum mechanical/molecular mechanical studies.
Capece L; Lewis-Ballester A; Batabyal D; Di Russo N; Yeh SR; Estrin DA; Marti MA
J Biol Inorg Chem; 2010 Aug; 15(6):811-23. PubMed ID: 20361220
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
[TBL] [Abstract][Full Text] [Related]
5. The role of serine 167 in human indoleamine 2,3-dioxygenase: a comparison with tryptophan 2,3-dioxygenase.
Chauhan N; Basran J; Efimov I; Svistunenko DA; Seward HE; Moody PC; Raven EL
Biochemistry; 2008 Apr; 47(16):4761-9. PubMed ID: 18370410
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Reaction Intermediates in Tryptophan 2,3-Dioxygenase: A Comparison with Indoleamine 2,3-Dioxygenase.
Basran J; Booth ES; Lee M; Handa S; Raven EL
Biochemistry; 2016 Dec; 55(49):6743-6750. PubMed ID: 27951658
[TBL] [Abstract][Full Text] [Related]
7. Heme-containing enzymes and inhibitors for tryptophan metabolism.
Yan D; Lin YW; Tan X
Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043
[TBL] [Abstract][Full Text] [Related]
8. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
10. IDO and TDO as a potential therapeutic target in different types of depression.
Qin Y; Wang N; Zhang X; Han X; Zhai X; Lu Y
Metab Brain Dis; 2018 Dec; 33(6):1787-1800. PubMed ID: 30014175
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
12. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO).
Pan S; Zhou Y; Wang Q; Wang Y; Tian C; Wang T; Huang L; Nan J; Li L; Yang S
Eur J Med Chem; 2020 Dec; 207():112703. PubMed ID: 32871341
[TBL] [Abstract][Full Text] [Related]
13. Role of indoleamine 2,3-dioxygenase in testicular immune-privilege.
Gualdoni GS; Jacobo PV; Sobarzo CM; Pérez CV; Matzkin ME; Höcht C; Frungieri MB; Hill M; Anegon I; Lustig L; Guazzone VA
Sci Rep; 2019 Nov; 9(1):15919. PubMed ID: 31685866
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.
Cui G; Lai F; Wang X; Chen X; Xu B
Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488
[TBL] [Abstract][Full Text] [Related]
16. Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes.
Yuasa HJ; Ball HJ
J Exp Zool B Mol Dev Evol; 2015 Mar; 324(2):128-40. PubMed ID: 25702628
[TBL] [Abstract][Full Text] [Related]
17. Exploring the mechanism of tryptophan 2,3-dioxygenase.
Thackray SJ; Mowat CG; Chapman SK
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1120-3. PubMed ID: 19021508
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases.
Dawood S; Bano S; Badawy AA
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506370
[TBL] [Abstract][Full Text] [Related]
19. Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy.
Brochez L; Kruse V; Schadendorf D; Muller AJ; Prendergast GC
Front Immunol; 2021; 12():789473. PubMed ID: 34938297
[No Abstract] [Full Text] [Related]
20. One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases.
Mammoli A; Riccio A; Bianconi E; Coletti A; Camaioni E; Macchiarulo A
ChemMedChem; 2021 Sep; 16(18):2732-2743. PubMed ID: 34137184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
